Wells Fargo’s Aclaris Therapeutics ACRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $89.2K | Buy |
62,840
+58,250
| +1,269% | +$82.7K | ﹤0.01% | 4845 |
|
2025
Q1 | $7.02K | Hold |
4,590
| – | – | ﹤0.01% | 5496 |
|
2024
Q4 | $11.4K | Hold |
4,590
| – | – | ﹤0.01% | 5409 |
|
2024
Q3 | $5.28K | Hold |
4,590
| – | – | ﹤0.01% | 5499 |
|
2024
Q2 | $5.05K | Sell |
4,590
-21,268
| -82% | -$23.4K | ﹤0.01% | 5490 |
|
2024
Q1 | $32.1K | Buy |
25,858
+5,779
| +29% | +$7.17K | ﹤0.01% | 5043 |
|
2023
Q4 | $21.1K | Buy |
20,079
+1,792
| +10% | +$1.88K | ﹤0.01% | 5191 |
|
2023
Q3 | $125K | Sell |
18,287
-13,880
| -43% | -$95.1K | ﹤0.01% | 4319 |
|
2023
Q2 | $334K | Buy |
32,167
+14,985
| +87% | +$155K | ﹤0.01% | 4025 |
|
2023
Q1 | $139K | Buy |
17,182
+9,596
| +126% | +$77.6K | ﹤0.01% | 4368 |
|
2022
Q4 | $119K | Buy |
7,586
+1,476
| +24% | +$23.2K | ﹤0.01% | 4167 |
|
2022
Q3 | $97K | Sell |
6,110
-217
| -3% | -$3.45K | ﹤0.01% | 4323 |
|
2022
Q2 | $89K | Sell |
6,327
-33,484
| -84% | -$471K | ﹤0.01% | 4445 |
|
2022
Q1 | $686K | Buy |
39,811
+7,013
| +21% | +$121K | ﹤0.01% | 3919 |
|
2021
Q4 | $477K | Sell |
32,798
-87,751
| -73% | -$1.28M | ﹤0.01% | 4391 |
|
2021
Q3 | $2.17M | Buy |
120,549
+119,438
| +10,750% | +$2.15M | ﹤0.01% | 3425 |
|
2021
Q2 | $20K | Sell |
1,111
-279
| -20% | -$5.02K | ﹤0.01% | 5562 |
|
2021
Q1 | $35K | Sell |
1,390
-31,546
| -96% | -$794K | ﹤0.01% | 5622 |
|
2020
Q4 | $213K | Buy |
32,936
+31,719
| +2,606% | +$205K | ﹤0.01% | 4922 |
|
2020
Q3 | $4K | Sell |
1,217
-1,019
| -46% | -$3.35K | ﹤0.01% | 5708 |
|
2020
Q2 | $3K | Sell |
2,236
-50,114
| -96% | -$67.2K | ﹤0.01% | 5673 |
|
2020
Q1 | $54K | Buy |
52,350
+26,213
| +100% | +$27K | ﹤0.01% | 5090 |
|
2019
Q4 | $49K | Sell |
26,137
-5,876
| -18% | -$11K | ﹤0.01% | 5261 |
|
2019
Q3 | $34K | Buy |
32,013
+7,047
| +28% | +$7.48K | ﹤0.01% | 5356 |
|
2019
Q2 | $54K | Sell |
24,966
-5,596
| -18% | -$12.1K | ﹤0.01% | 5237 |
|
2019
Q1 | $184K | Buy |
30,562
+3,329
| +12% | +$20K | ﹤0.01% | 4793 |
|
2018
Q4 | $201K | Buy |
27,233
+11,498
| +73% | +$84.9K | ﹤0.01% | 4713 |
|
2018
Q3 | $229K | Buy |
15,735
+854
| +6% | +$12.4K | ﹤0.01% | 4766 |
|
2018
Q2 | $297K | Sell |
14,881
-433
| -3% | -$8.64K | ﹤0.01% | 4664 |
|
2018
Q1 | $269K | Buy |
15,314
+87
| +0.6% | +$1.53K | ﹤0.01% | 4652 |
|
2017
Q4 | $376K | Sell |
15,227
-26,577
| -64% | -$656K | ﹤0.01% | 4465 |
|
2017
Q3 | $1.08M | Buy |
41,804
+921
| +2% | +$23.8K | ﹤0.01% | 3735 |
|
2017
Q2 | $1.11M | Buy |
40,883
+28,524
| +231% | +$774K | ﹤0.01% | 3602 |
|
2017
Q1 | $369K | Buy |
12,359
+5,900
| +91% | +$176K | ﹤0.01% | 4322 |
|
2016
Q4 | $175K | Buy |
6,459
+3,193
| +98% | +$86.5K | ﹤0.01% | 4662 |
|
2016
Q3 | $84K | Buy |
3,266
+1,617
| +98% | +$41.6K | ﹤0.01% | 4802 |
|
2016
Q2 | $30K | Sell |
1,649
-209
| -11% | -$3.8K | ﹤0.01% | 5125 |
|
2016
Q1 | $30K | Buy |
1,858
+198
| +12% | +$3.2K | ﹤0.01% | 5187 |
|
2015
Q4 | $45K | Buy |
+1,660
| New | +$45K | ﹤0.01% | 5108 |
|